Anzeige
Mehr »
Login
Donnerstag, 28.03.2024 Börsentäglich über 12.000 News von 687 internationalen Medien
Spezial am Donnerstag: Rallye II. - Neuer Anstoß, News und was die Börsencommunity jetzt nicht verpassen will…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1CYM1 | ISIN: US74345W1080 | Ticker-Symbol: QGY
Berlin
28.03.24
08:08 Uhr
5,700 Euro
-0,050
-0,87 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
PROPHASE LABS INC Chart 1 Jahr
5-Tage-Chart
PROPHASE LABS INC 5-Tage-Chart

Aktuelle News zur PROPHASE LABS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
18.03.ProPhase Labs, Inc. - NT 10-K, Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT4051
18.03.ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript1
15.03.Prophase Labs Inc reports results for the quarter ended in December - Earnings Summary1
15.03.ProPhase Labs, Inc.: ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives68Nebula Genomics secures major international B2B deal - Additional significant B2B deals in final stages Ahead of schedule, Pharmaloz Manufacturing accelerates capacity expansion - set for rapid...
► Artikel lesen
15.03.ProPhase Labs GAAP EPS of -$0.98 misses by $0.24, revenue of $45.2M misses by $6.38M1
15.03.ProPhase Labs, Inc. - 8-K, Current Report1
14.03.ProPhase Labs FY 2023 Earnings Preview1
08.03.ProPhase Labs, Inc.: PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 20241
14.02.ProPhase Labs, Inc.: ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir305Commercialization of Equivir anticipated after second trial is completed in Q2, 2024 Garden City, NY, Feb. 14, 2024 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH), a next generation biotech...
► Artikel lesen
23.01.ProPhase Labs eyes higher revenue for lozenge-making unit with improved pricing1
23.01.ProPhase Labs, Inc.: Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts388Pharmaloz Wins Two New Contracts in January that are Anticipated to Significantly Increase Lozenge Revenues and ProfitabilityCompany in Late-Stage Discussions with Two Additional Large Global Brands...
► Artikel lesen
04.01.ProPhase Labs, Inc. - 8-K, Current Report-
13.11.23ProPhase Labs, Inc. - 10-Q, Quarterly Report1
09.11.23Prophase Labs Inc reports results for the quarter ended in September - Earnings Summary1
09.11.23ProPhase Labs reports Q3 results1
09.11.23ProPhase Labs, Inc. - 8-K, Current Report1
08.11.23ProPhase Labs Q3 2023 Earnings Preview1
08.11.23ProPhase Labs Earnings Preview1
02.11.23 ProPhase Labs, Inc.: ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time1
17.10.23ProPhase Labs, Inc.: ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.1
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1